It's never fun when you see one of your holdings sell off ~20% or so in a single trading day. This typically means that something has gone terribly wrong and can really test an investor's intestinal fortitude. Thankfully, I don't invest in companies that experience this sort of volatility very often. The vast majority of my portfolio is made up of large cap, relatively conservative, well established companies with stable cash flows and long histories of reliable dividend growth. However, I have decided a small portion of my portfolio to more speculative, growth oriented names. This keeps me on my toes as an investor and adds a bit of octane to my portfolio's fuel with regard to long-term total returns. One of these non-dividend paying growth oriented companies that I own is Celgene (CELG). Unfortunately for me, this stock has sold off to the tune of 34% in the last couple of weeks since hitting 52 week highs in early October. Admittedly, the company has posted a couple of negative news items that have impacted the stock; however, I think this move from $147 down to $96 was simply too much, too fast. Because of this, I added to my CELG position at $96.03 on Thursday during its post-earnings sell-off.
